Evercore analyst Vijay Kumar maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $385 to $490.
According to TipRanks data, the analyst has a success rate of 56.7% and a total average return of 5.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's third-quarter earnings outperformance was highlighted by solid results, driven by placements of the Da Vinci 5 system, significant growth in procedure volume, and maintained margins. Furthermore, the company's management has adjusted its full-year procedure volume growth forecast, now anticipating an increase to a range between 16%-17%, factoring in potential fluctuations in bariatric procedures and the challenging environment in Asia, including ongoing physician strikes in Korea.
The expectation is that the Street is anticipating a significant revenue outperformance for FY25. This comes in the wake of the company's quarterly report, after which estimates for FY25 EPS were increased by approximately 3%.
Intuitive Surgical reported 'strong' third-quarter results, with the two most crucial metrics - new system placements and growth in procedures - surpassing expectations. Following the approval of the da Vinci 5 in the U.S., the company is witnessing significant growth momentum. The initial uptake of the DV5 is progressing faster than the fourth-generation system's launch, with promising signs that suggest a potential growth acceleration in the year 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
Evercore分析師Vijay Kumar維持$直覺外科公司 (ISRG.US)$持有評級，並將目標價從385美元上調至490美元。
根據TipRanks數據顯示，該分析師近一年總勝率為56.7%，總平均回報率為5.5%。
此外，綜合報道，$直覺外科公司 (ISRG.US)$近期主要分析師觀點如下：
直覺外科公司第三季度的盈利表現突出，主要得益於達芬奇5系統的安置情況，手術量的顯著增長以及保持的利潤率。此外，該公司的管理層已調整了全年手術量增長預測，現在預計將在16%-17%的區間內增長，考慮到減重手術可能波動以及亞洲的困難環境，包括韓國持續發生的醫生罷工。
市場預期街道將在2025財年實現顯著的營業收入超額表現。這是在公司季度報告之後，預計2025財年每股收益增長約3%之後。
直覺外科公司報告了 '強勁' 的第三季度業績，最關鍵的兩個指標 - 新系統安置和手術量增長 - 超出了預期。在美國批准達芬奇5後，該公司正在經歷顯著的增長動力。DV5的初始接受速度比第四代系統的推出更快，有跡象表明2025年可能出現增長加速。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
